SP Shuttle Pharmaceuticals Holdings, Inc. Stock: price and management transactions · United States · SEC (Form 4)Source id SEC:shuttle-pharmaceuticals-holdings-inc-232dd9 US · SEC (Form 4) Mcap US$2.3B Follow the Shuttle Pharmaceuticals Holdings, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 15 July 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. All data is free.
€483,917
17 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate Shuttle Pharmaceuticals Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Buys €50,766 €483,917 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 July 2026
All Executives23 Thresholds0 Prospectus0 Other0
Declarations 23 total
▼ 10% Owner · Executives · 13 Jul 2026
1,033 shares @ US$4.67 0.0002% mcap 0.9% of flow Common Stock SEC:0001475597-26-000159:0
▼ 10% Owner · Executives · 14 Jul 2026
82,116 shares @ US$4.48 0.019% mcap 65.4% of flow Common Stock SEC:0001475597-26-000159:1
▲ 10% Owner · Executives · 9 Jul 2026
8,266 shares @ US$3.38 0.0014% mcap 14.7% of flow Common Stock SEC:0001475597-26-000154:0
Canonical exit: 7 Oct 2026 (T+90) ▲ 10% Owner · Executives · 10 Jul 2026
731 shares @ US$3.11 0.0001% mcap 1.2% of flow Common Stock SEC:0001475597-26-000154:1
Canonical exit: 8 Oct 2026 (T+90) ▼ 10% Owner · Executives · 7 Jul 2026
10,580 shares @ US$3.33 0.0018% mcap 22.0% of flow Common Stock SEC:0001475597-26-000144:0
▼ 10% Owner · Executives · 8 Jul 2026
18,531 shares @ US$3.52 0.0033% mcap 40.9% of flow Common Stock SEC:0001475597-26-000144:1
▲ 10% Owner · Executives · 2 Jul 2026
7,851 shares @ US$3.54 0.0015% mcap 46.8% of flow Common Stock SEC:0001475597-26-000138:0
Canonical exit: 30 Sept 2026 (T+90) ▼ 10% Owner · Executives · 6 Jul 2026
9,022 shares @ US$3.51 0.0018% mcap 53.2% of flow Common Stock SEC:0001475597-26-000138:1
◆ Chief Scientific Officer · Executives · 1 May 2024
598 shares @ US$11.28 92.7% of flow CLASS A COMMON STOCK SEC:0001493152-24-040614:0
▼ Director · Executives · 29 Dec 2022
1,626 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-24-009980:0
◆ Chief Financial Officer · Executives · 8 Mar 2024
100,000 shares 0COMMON STOCK SEC:0001493152-24-009451:0
▼ Director · Executives · 13 Dec 2023
2,921 shares @ US$0.4632 45.5% of flow Common Stock SEC:0001493152-24-000125:0
▼ Director · Executives · 13 Dec 2023
4,157 shares @ US$0.4632 21.3% of flow Common Stock SEC:0001493152-23-045648:0
● CEO and Chairman · Executives · 14 Aug 2023
2,100,000 shares 0COMMON STOCK SEC:0001493152-23-029472:0
▼ Director · Executives · 29 Dec 2022
995 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-23-000941:0
995 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-23-000319:0
▼ Director · Executives · 29 Dec 2022
995 shares @ US$1.605 54.5% of flow COMMON STOCK SEC:0001493152-23-000318:0
▼ CEO and Chairman · Executives · 29 Dec 2022
8,372 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-23-000026:0
▼ Chief Scientific Officer · Executives · 29 Dec 2022
328 shares @ US$1.605 7.3% of flow CLASS A COMMON STOCK SEC:0001493152-23-000013:0
▼ Chief Medical Officer · Executives · 29 Dec 2022
1,414 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-23-000014:0
▼ Director · Executives · 29 Dec 2022
4,366 shares @ US$1.605 78.7% of flow CLASS A COMMON STOCK SEC:0001493152-23-000012:0
▼ President and COO · Executives · 29 Dec 2022
3,820 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-22-037210:0
▼ Chief Financial Officer · Executives · 29 Dec 2022
2,243 shares @ US$1.605 100.0% of flow COMMON STOCK SEC:0001493152-22-037141:0
关于 Shuttle Pharmaceuticals Holdings, Inc. Shuttle Pharmaceuticals Holdings, Inc. 是一家专注于开发创新药物治疗的公司。它专门研究和商业化严重疾病的治疗解决方案。